| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants
|
Clack, Glen
|
|
|
42 |
1 |
p. 216-232
|
article
|
| 2 |
A Response to: Letter to the Editor Regarding “Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis”
|
Snyman, Jacques R.
|
|
|
42 |
1 |
p. 552-555
|
article
|
| 3 |
A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria
|
Clayton, Denise
|
|
|
42 |
1 |
p. 500-509
|
article
|
| 4 |
Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis
|
Klimchak, Alexa C.
|
|
|
42 |
1 |
p. 523-536
|
article
|
| 5 |
Clinical Characteristics and Treatment of Patients Diagnosed with Pulmonary Arterial Hypertension: A Real-World Study in the USA, Europe and Japan
|
Vizza, C. D.
|
|
|
42 |
1 |
p. 193-215
|
article
|
| 6 |
Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO)
|
Khattri, Saakshi
|
|
|
42 |
1 |
p. 233-245
|
article
|
| 7 |
Correction to: Effcacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
|
Li, Xia
|
|
|
42 |
1 |
p. 164
|
article
|
| 8 |
Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)
|
Simpson, Eric
|
|
|
42 |
1 |
p. 144-145
|
article
|
| 9 |
Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023
|
Igarashi, Ataru
|
|
|
42 |
1 |
p. 70-71
|
article
|
| 10 |
Correction to: Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese Population
|
Retat, Lise
|
|
|
42 |
1 |
p. 556-558
|
article
|
| 11 |
Cost-Effectiveness Analysis of Pharmaceutical-Grade Chondroitin Sulfate for Knee Osteoarthritis Based on Individual Patient Data from a Randomized Clinical Trial
|
Bruyère, Olivier
|
|
|
42 |
1 |
p. 165-173
|
article
|
| 12 |
Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy
|
Paulissen, Jeroen Hendrikus Jacobus
|
|
|
42 |
1 |
p. 322-333
|
article
|
| 13 |
Cost-Effectiveness of Vibrant System vs. Linaclotide in Chronic Idiopathic Constipation
|
Voigt, Jeffrey D.
|
|
|
42 |
1 |
p. 310-321
|
article
|
| 14 |
Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes Mellitus in France and Italy: A Retrospective Cohort Study
|
Khare, Swarna
|
|
|
42 |
1 |
p. 174-192
|
article
|
| 15 |
Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review
|
Rossi, Mariateresa
|
|
|
42 |
1 |
p. 94-105
|
article
|
| 16 |
Efanesoctocog Alfa Versus Emicizumab in Adolescent and Adult Patients With Haemophilia A Without Inhibitors
|
Álvarez Román, María Teresa
|
|
|
42 |
1 |
p. 442-455
|
article
|
| 17 |
Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without Inhibitors
|
Klamroth, Robert
|
|
|
42 |
1 |
p. 427-441
|
article
|
| 18 |
Effect of Cariprazine on Anhedonia in Patients with Bipolar I Depression: Post Hoc Analysis of Three Randomized Placebo-Controlled Clinical Trials
|
McIntyre, Roger S.
|
|
|
42 |
1 |
p. 246-260
|
article
|
| 19 |
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps
|
Jacobs, Joshua S.
|
|
|
42 |
1 |
p. 510-522
|
article
|
| 20 |
Efficacy and Safety Analysis in Chinese Patients with Moderate-to-Severe Psoriasis from a Phase 3 Trial: Impact of Treatment Withdrawal and Retreatment of Ixekizumab
|
Gao, Xinghua
|
|
|
42 |
1 |
p. 334-347
|
article
|
| 21 |
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
|
Li, Xia
|
|
|
42 |
1 |
p. 146-163
|
article
|
| 22 |
Endoscopic Minimally Invasive Approach Versus Median Sternotomy for Multiple-Valve Surgery: A Propensity-Matched Analysis
|
Salamate, Saad
|
|
|
42 |
1 |
p. 261-279
|
article
|
| 23 |
Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Dialysis-Dependent Patients with Anaemia of Chronic Kidney Disease: A Retrospective Observational Study
|
Atzinger, Christopher
|
|
|
42 |
1 |
p. 471-489
|
article
|
| 24 |
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)
|
Simpson, Eric
|
|
|
42 |
1 |
p. 132-143
|
article
|
| 25 |
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023
|
Igarashi, Ataru
|
|
|
42 |
1 |
p. 52-69
|
article
|
| 26 |
Integrating Genetic Insights, Technological Advancements, Screening, and Personalized Pharmacological Interventions in Childhood Obesity
|
Šket, Robert
|
|
|
42 |
1 |
p. 72-93
|
article
|
| 27 |
Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan
|
Mizuno, Seiko
|
|
|
42 |
1 |
p. 413-426
|
article
|
| 28 |
Letter to the Editor Regarding “Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis”
|
Leong, Trudy D.
|
|
|
42 |
1 |
p. 548-551
|
article
|
| 29 |
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD
|
Tse, Gary
|
|
|
42 |
1 |
p. 375-394
|
article
|
| 30 |
Our Experience in Treating Infantile Hemangioma: Prognostic Factors for Relapse After Propranolol Discontinuation
|
Zaaroura, Hiba
|
|
|
42 |
1 |
p. 537-547
|
article
|
| 31 |
Patient Satisfaction Scale Following a Laxative for Antibiotic Washout Prior to Oral Microbiome Therapy
|
Chua, Hubert C.
|
|
|
42 |
1 |
p. 490-499
|
article
|
| 32 |
Predicting Asthma Exacerbations Using Machine Learning Models
|
Turcatel, Gianluca
|
|
|
42 |
1 |
p. 362-374
|
article
|
| 33 |
Predictors for Irreversibility of Contrast-Induced Acute Kidney Injury in Patients with Obesity After Contrast-Enhanced Computed Tomography Coronary Angiography
|
Berezina, Tetiana A.
|
|
|
42 |
1 |
p. 293-309
|
article
|
| 34 |
Prognostic Impact of Neutropenia Recovery and G-CSF Use in Onco-Hematological Neutropenic Patients Admitted to Intensive Care Unit for Acute Respiratory Failure: A Retrospective, Real World Analysis
|
Secreto, Carolina
|
|
|
42 |
1 |
p. 280-292
|
article
|
| 35 |
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients
|
Mao-Draayer, Yang
|
|
|
42 |
1 |
p. 395-412
|
article
|
| 36 |
Sacral and Implantable Tibial Neuromodulation for the Management of Overactive Bladder: A Systematic Review and Meta-analysis
|
Amundsen, Cindy L.
|
|
|
42 |
1 |
p. 10-35
|
article
|
| 37 |
Secondary Risk-Reducing Strategies for Contralateral Breast Cancer in BRCA1/2 Variant Carriers: A Systematic Review and Meta-analysis
|
Yu, Jing
|
|
|
42 |
1 |
p. 106-131
|
article
|
| 38 |
Therapeutic Applications for Homeopathy in Clinical Practice
|
Maftei, Nicoleta Maricica
|
|
|
42 |
1 |
p. 36-51
|
article
|
| 39 |
Understanding Influenza Vaccine Clinical Performance: A Podcast
|
Desai, Nihar R.
|
|
|
42 |
1 |
p. 1-9
|
article
|
| 40 |
Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental Impact
|
Garcia Sanchez, Juan Jose
|
|
|
42 |
1 |
p. 348-361
|
article
|
| 41 |
Utility of Loneliness Status to Risk Stratification and Prediction of Recurrent Atrial Fibrillation After Catheter Ablation
|
Sun, Huaxin
|
|
|
42 |
1 |
p. 456-470
|
article
|
Journal description